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White spot syndrome virus (WSSV) virions were purified from the tissues of infected Procambarus clarkii
(crayfish) isolates. Pure WSSV preparations were subjected to Triton X-100 treatment to separate into the
envelope and nucleocapsid fractions, which were subsequently separated by 12% sodium dodecyl sulfate-
polyacrylamide gel electrophoresis. The major envelope and nucleocapsid proteins were identified by either
matrix-assisted laser desorption ionization–time of flight mass spectrometry or defined antibody. A total of 30
structural proteins of WSSV were identified in this study; 22 of these were detected in the envelope fraction,
7 in the nucleocapsid fraction, and 1 in both the envelope and the nucleocapsid fractions. With the aid of
specific antibodies, the localizations of eight proteins were further studied. The analysis of posttranslational
modifications revealed that none of the WSSV structural proteins was glycosylated and that VP28 and VP19
were threonine phosphorylated. In addition, far-Western and coimmunoprecipitation experiments showed that
VP28 interacted with both VP26 and VP24. In summary, the data obtained in this study should provide an
important reference for future molecular studies of WSSV morphogenesis.
White spot syndrome virus (WSSV) is a major pathogen in
the cultured penaeid shrimp and can also infect most species of
crustaceans (2, 4, 6, 10, 22). Electron microscopy studies re-
vealed that the WSSV virion is an enveloped, nonoccluded,
and rod-shaped particle of approximately 275 by 120 nm in size
(37, 39). The virus contains a double-stranded circular DNA of
about 300 kb, which has been completely sequenced on three
WSSV isolates (30, 43). Subsequent analysis revealed that the
WSSV genome includes about 180 open reading flames
(ORFs). However, so far, only about 30% of these ORFs were
functionally annotated, including structural proteins and a va-
riety of enzymes involved in DNA replication and repair, gene
transcription, and protein modification, and the other potential
gene products are known only as hypothetical proteins. On the
basis of phylogenetic analysis, WSSV has been classified in a
novel virus genus, Whispovirus, and family, Nimaviridae, as a
sole member (23, 24).
With the elucidation of the WSSV genome, at present more
attention has been paid to the identification and functional
analysis of viral structural proteins, because they are consid-
ered to be the key molecules that interact first with the host. In
previous studies, the major proteins of WSSV, such as VP28,
VP26, VP24, VP19, and VP15, have been analyzed by sodium
dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-
PAGE) and identified by N-terminal sequencing (31–33). The
recent attempts to identify the minor WSSV structural proteins
relied on the combination of 1D or 2D gel electrophoresis
separation and mass spectrometry (MS) followed by database
searches, which is proven to be a fast and sensitive method for
the identification of genes at the protein level (26). And so far,
more than 30 polypeptides matching WSSV ORFs were iden-
tified with a molecular mass range of 7 to 660 kDa by using this
approach (11, 29, 44). However, because of the lack of cell
culture systems capable of supporting WSSV replication, many
questions concerning viral structure, nature, and function re-
main to be elucidated.
For enveloped viruses, the envelope proteins are particularly
important because these proteins often play vital roles in virus
entry, assembly, and budding (3). In previous studies, intensive
efforts have been undertaken for characterization of the enve-
lope proteins of WSSV, but these previous approaches were
focused on the analysis of individual proteins or a limited
number of proteins and the overall biochemical composition of
the envelope has for the most part remained elusive. Although
the nucleocapsid of WSSV contains relatively few proteins
compared with the envelope (42), the characterization of the
nucleocapsid proteins is also poorly studied. At present, only
two proteins (VP15 and VP664) are confirmed to be nucleo-
capsid associated (19, 31). Ultrathin section electron micros-
copy analysis revealed that the replication and assembly of
WSSV take place in the nucleus (16, 21), but little is known
about the molecular events occurring during the assembly.
With this in mind, we decided to make a more comprehensive
proteomic analysis, the goal of which was to identify and fur-
ther characterize the major envelope and nucleocapsid pro-
teins of WSSV. By systematically defining the protein compo-
sition of the envelope and nucleocapsid, a functional protein
map of WSSV may be realized.
In this study, we have separated the envelope and nucleo-
capsid proteins of purified WSSV virions by 1D gel electro-
phoresis. The major envelope and nucleocapsid proteins
were identified by using either matrix-assisted laser desorp-
tion ionization (MALDI) MS or defined antibodies. The
structural proteins of WSSV were further characterized by
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analysis of glycosylation and phosphorylation. Finally, far-
Western and coimmunoprecipitation experiments were con-
ducted to identify the interaction between VP28 and other
structural proteins.
MATERIALS AND METHODS
Purification of WSSV virion. The purification of WSSV was performed as
described previously with slight modification on ice or at 4°C (42). Briefly, five to
six moribund crayfish (20 to 25 g each) were collected at 1 week postinfection; all
tissues excluding hepatopancreas were homogenized for 2 min using a mechan-
ical homogenizer (IKA T-25) in 1,200 ml TNE buffer (50 mM Tris-HCl, 400 mM
NaCl, 5 mM EDTA, pH 8.5) containing protease inhibitors (1 mM phenylmethyl-
sulfonyl fluoride, 1 mM benzamidine, and 1 mM Na2S2O5) and then centrifuged
at 3,500  g for 5 min using a JA-14 rotor (Avanti JE; Beckman). The super-
natant was saved, and the pellet was rehomogenized in 1,200 ml TNE buffer. The
pooled supernatant was filtered through a nylon net (400 mesh) and centrifuged
at 30,000  g for 30 min. After the supernatant was discarded, the upper loose
layer (pink) of pellet was rinsed out carefully using a Pasteur pipette, and the
lower compact layer (gray) was resuspended in 10 ml TM buffer (50 mM Tris-
HCl, 10 mM MgCl2, pH 7.5). The crude virus suspensions were pooled and
centrifuged at 3,000  g for 5 min using a JA-20 rotor, and the supernatant was
centrifuged again at 30,000  g for 20 min. After the supernatant and pink loose
layer were removed, the white pellet was resuspended in 1.2 ml TM buffer
containing 0.1% NaN3 and transferred to a 1.5-ml Eppendorf tube. The suspen-
sion was centrifuged three to five times at 650  g for 5 min each time to remove
pink impurities. Finally, the milk-like pure virus suspension was stored at 4°C
until use. The purity of the virus preparation was evaluated by negative-staining
transmission electron microscopy (TEM) (JEM 100 cx).
Preparation of the envelope and nucleocapsid fractions. The purified virus
suspension was divided into two equal portions and centrifuged at 20,000  g for
30 min at 4°C. The pellets were resuspended in 0.4 ml of salt-free buffer (20 mM
Tris-HCl, 2 mM MgCl2, pH 7.5) and salt-containing buffer TMN (20 mM Tris-
HCl, 150 mM NaCl, 2 mM MgCl2, pH 7.5). For each group, the virus suspension
was divided into eight equal portions and subjected to treatment with four
different detergents at two concentrations (0.1% and 1%), the nonionic detergent
Triton X-100 (TX), octyl glucopyranoside (OG), the zwitterionic detergent 3-[(3-
cholamidopropyl)-dimethylammonio]-1-propanesulfonate (CHAPS), and the ionic
detergent sodium deoxycholate (NaDC), for 30 min at room temperature with
gentle shaking. Subsequently, the samples were separated into two fractions, super-
natant and pellet, by centrifugation at 20,000  g for 20 min at 4°C. The pellet was
rinsed with water to eliminate any residual supernatant solution and then resus-
pended in TMN buffer. Finally, all samples were mixed with an equal volume of 2
Laemmli sample buffer, resolved by SDS-PAGE, and stained with Coomassie bril-
liant blue (15).
Identification of the proteins by MALDI MS. (i) In-gel enzymatic digestion of
protein. Stained protein bands were excised from gels, cut into pieces, and
transferred to a 1.5-ml microcentrifuge tube. The gel pieces were washed twice
with 50% acetonitrile in 50 mM ammonium bicarbonate for 20 min each time,
dehydrated with 100% acetonitrile for 10 min, and vacuum dried. For enzymatic
digestion, 125 ng of modified trysin (sequencing grade; Promega) was dissolved
in 10 l of 50 mM ammonium bicarbonate and gradually added to the dry gel
pieces. After being reswollen at 4°C for 30 min, samples were incubated over-
night at 37°C. Following digestion, tryptic peptides were extracted twice with 60
l of 50% acetonitrile and 0.1% trifluoroacetic acid for 30 min each time. The
extracted solutions were pooled and vacuum dried for subsequent MS analysis.
(ii) MALDI-TOF/TOF MS. The matrix used was a saturated solution of
-cyano-4-hydroxycinnamic acid in 50% acetonitrile and 0.1% trifluoroacetic
acid. The dried peptides were dissolved in 0.7 l of the matrix, deposited on the
target plate, and allowed to dry at room temperature. MALDI mass spectra were
obtained using a 4700 Proteomics Analyzer with time-of-flight (TOF)/TOF op-
tics (Applied Biosystems) fitted with a 355-nm Nd:YAG laser. Spectra were
acquired in positive-ion reflector mode with an acceleration voltage of 20 kV.
Instrumental control was performed with 4700 Explorer software, and GPS
Explorer software was used to process data as well as to search the nonredundant
database at the National Center for Biotechnology Information (NCBI), using
the Mascot platform (Matrix Science, London, United Kingdom) with the fol-
lowing parameters: peptide mass fingerprint, 0.3 Da; MS/MS sequence tag, 0.4
Da; allowing one uncleaved tryptic site; and allowing oxidation of methionine
and carbamidomethylation of cysteines.
Antibodies and Western blotting. Polyclonal antibodies against specific WSSV
structural proteins were generated in mouse by using the expressed recombinant
proteins in Escherichia coli as described previously (40). For Western blotting,
proteins dissolved in Laemmli sample buffer were separated by SDS-PAGE and
then transferred onto a polyvinylidene fluoride membrane (Amersham) by semi-
dry blotting at a constant current of 0.5 mA cm2 for 1.5 h at room temperature.
The blot was immersed in blocking buffer (20 mM Tris-HCl, 150 mM NaCl,
0.05% Tween 20, 3% nonfat milk, pH 7.5) at 4°C overnight, followed by incu-
bation with diluted primary antibody for 1 h at room temperature. Subsequently,
the blot was washed three times and incubated with secondary antibody (1:
7,500), an alkaline phosphatase (AP)-conjugated goat anti-mouse immunoglob-
ulin G (Promega), for 1 h at room temperature. After the blot was washed three
times, the detection was performed with BCIP (5-bromo-4-chloro-3-indolylphos-
phate)/Nitro Blue Tetrazolium (Roche).
Glycosylation and phosphorylation analysis of WSSV structural proteins. The
glycosylation detection of WSSV structural proteins in gels was performed ac-
cording the manual of the Pro-Q Emeral 300 glycoprotein stain kit (Invitrogen).
The glycoprotein stain reacts with periodate-oxidized carbohydrate groups and
creates a bright green fluorescent signal easily visualized using 300 nm UV
illumination on glycoproteins, providing much more sensitive glycoprotein de-
tection than the standard periodic acid-Schiff base method using acidic fuchsin
dye. The phosphorylation status of WSSV structural proteins was investigated
using Western blotting as described above. The primary antibody was a biotin-
conjugated mouse monoclonal antibody (Sigma) directed against phosphothreo-
nine (1:10,000), phosphotyrosine (1:5,000), or phosphoserine (1:40,000), and the
secondary antibody was AP-conjugated streptavidin (1:5,000; Promega).
Expression and purification of recombinant VP28 (rVP28). The entire VP28
gene was amplified from the genomic DNA of WSSV with the forward primer
5-GAGAGCATGCTTGATCTTTCTTTCACTCT-3 and the reverse primer 5-
GAGAGGATCCCTCGGTCTCAGTGCCAG-3 (SphI and BamHI restriction
sites underlined). The PCR product was digested with SphI and BamHI and
cloned into pQE-70 vector, and the recombinant plasmid was transformed into E.
coli XL-Blue. The bacterial cultures were induced with 0.1 mM isopropyl--D-
thiogalactopyranoside (IPTG) for 6 h at 37°C and then harvested. The recombinant
protein was purified using a column of Ni-nitriloacetic acid resins (QIAGEN) under
denatured conditions according to the instructions for QIAexpressionist and rena-
tured as described previously (20).
Biotinylation of proteins and far-Western experiments. The protein was dia-
lyzed against phosphate-buffered saline (PBS) with a 10-fold molar excess of
sulfo-NHS-LC-biotin (Pierce). The mixture was incubated at room temperature
for 30 min and dialyzed against PBS to remove the unreacted biotin reagent.
The viral envelope proteins were separated by SDS-PAGE and transferred to
a polyvinylidene fluoride membrane. Proteins adsorbed to the membrane were
renatured in turn by incubation with renaturation buffer (20 mM Tris-HCl, 150
mM NaCl, 2% nonfat milk, 1 mM EDTA, 25 mM dithiothreitol, 0.1% Tween 20,
10% glycerol, pH 7.5) containing 6 M, 3 M, 1 M, or 0.1 M guanidine-HCl at room
temperature for 1 h each time and then put in renaturation buffer overnight at
4°C. The blot was washed and incubated with 0.5 g of biotinylated rVP28 in 5
ml renaturation buffer for 3 h at room temperature. The blot was subsequently
washed three times and incubated with AP-conjugated streptavidin for 1 h at
room temperature. After the blot was washed three times, the detection was
performed as described above. Biotinylated glutathione S-transferase (GST) was
used to incubate with viral envelope proteins as a control.
Coimmunoprecipitation experiments. The viral envelope proteins were la-
beled with fluorescein isothiocyanate (FITC) as described previously (40). The
FITC-labeled envelope proteins were incubated with anti-VP28 serum or anti-
GST serum (1:250) as a negative control overnight at 4°C. Subsequently, protein
A-Sepharose beads were added to the mixture and incubated for 1 h at 4°C. The
Sepharose beads were collected by centrifugation and washed five times with
PBS. The bound proteins were dissociated from the antibody by boiling in
Laemmli sample buffer for 10 min and separated by SDS-PAGE. After electro-
phoresis, the gel was scanned by a Typhoon 9210 scanner (GE Healthcare).
RESULTS
Preparation of pure WSSV samples and separation of the
envelope and nucleocapsid proteins. Due to the lack of a
continuous cell culture system for large-scale production of
WSSV virions, it is rather difficult to purify a large amount of
WSSV virions with high quality. To overcome the disadvan-
tage, we established and optimized a simple and efficient pro-
tocol for WSSV purification. After multiple rounds of conven-
tional differential centrifugations, the milk-like virus suspension
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was obtained from infected crayfish tissues and TEM observation
revealed that most of the purified virions were intact (Fig. 1A).
To separate optimally the envelope and nucleocapsid frac-
tions from purified WSSV virion preparations, we first tested
the effects of four different detergents (TX, OG, CHAPS, and
NaDC) and their concentrations on the extraction of envelope
proteins from the virions. After detergent treatment and cen-
trifugation, the supernatant and pellet fractions were subse-
quently analyzed by SDS-PAGE. The efficiency of each deter-
gent solution was determined by the intensities of known
envelope proteins (e.g., VP28 and VP19) in the supernatant
fraction. As can be seen in Fig. 1C, TX was more efficient in
solubilizing envelope proteins than the other three detergents
under low-detergent (0.1%) conditions. About 90% of VP28
and VP19 was soluble in the presence of TX (Fig. 1C, lane 1),
whereas an estimated 90, 70, and 80% remained in the pellet
fraction in the presence of OG (lane 10), CHAPS (lane 18),
and NaDC (lane 26), respectively. In addition, for each of the
four detergents, better protein solubilization was achieved
when the detergent concentration was increased from 0.1% to
1% (Fig. 1C, lanes 5, 13, 21, and 29). We also tested the effect
of the salt (NaCl) concentration on the extraction of envelope
proteins. The results revealed that increasing the concentra-
tion of NaCl (up to 0.15 M) could enhance envelope protein
solubility (Fig. 1C, lanes 3, 7, 11, 15, 19, 23, 27, and 31),
especially in the case of VP26 and another protein with an
apparent molecular mass of 95 kDa (termed VP95). Finally, we
tested the effect of reducing agents, such as dithiothreitol, on
the extraction of envelope proteins. The result showed that the
addition of a reducing agent had no effect on the partitioning
of proteins, suggesting that there are no disulfide bond inter-
actions between envelope and nucleocapsid proteins (data not
shown). Based on these data, we conclude that to obtain the
optimal and most-reproducible extraction results, the use of
1% Triton X-100, as well as 0.15 M NaCl, was required. Under
this condition, VP28 and VP19 were present completely in the
supernatant fraction (Fig. 1C, lanes 7 and 8). Figure 1B
showed the viral nucleocapsids from the resulting pellet of TX
treatment. Another commonly used detergent, Nonidet P-40
(NP-40), was also utilized to solubilize envelope proteins, and
FIG. 1. (A) TEM of purified WSSV virions. Bar 	 200 nm. (B) TEM of WSSV nucleocapsids after treatment with 1% TX and 0.15 M NaCl.
Bar 	 100 nm. (C) Coomassie brilliant blue-stained 12% SDS-PAGE gel of the supernatant (S) and pellet (P) fractions of WSSV virions after
treatment with four detergents at different detergent (0.1% and 1%) and salt (0 M and 0.15 M NaCl) concentrations. M, protein molecular mass
marker (kDa). VP95, VP28, VP26, VP24, VP19, and VP15 are indicated on the right.
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the protein profile extracted was identical to that of TX (data
not shown).
Identification of WSSV proteins. Under optimal treatment
conditions, WSSV envelope and nucleocapsid fractions were
separated by SDS-PAGE; the resulting protein bands are
shown clearly in Fig. 2. Twenty-five distinct protein bands
ranging from 10 to 200 kDa could be observed in the viral
envelope fraction. In the nucleocapsid fraction, only eight pro-
tein bands were readily seen. A total of 33 prominent bands
(Fig. 2) were excised individually from the gels and further
analyzed by MS. MALDI mass spectra of tryptic peptides of
each protein were generated and sequenced against the NCBI
nonredundant database using the Mascot platform. In total, 29
genes from the WSSV genome were identified with 6 to 64%
coverage of amino acid sequences. Proteins encoded by wsv011
and wsv442 were found in more than one band, while both
band 12 and band 13 contained two proteins (Table 1).
Band 33 of the nucleocapsid fraction could not be identified
by MALDI MS. Based on its apparent molecular mass, it
should be the major nucleocapsid protein VP15 (31). Sequence
analysis shows that VP15 contains 14 arginines and 13 lysines
in a total of 61 amino acids (45), so it seemed that the tryptic
fragments of VP15 were too small to identify by MALDI MS.
Western blotting using specific antibody against VP15 con-
firmed that this band was indeed VP15 (data not shown).
Of 30 proteins identified in this study, 22 were detected in
the envelope fraction, 7 in the nucleocapsid fraction, and 1 in
both the envelope and the nucleocapsid fractions (Fig. 2; Table
1). Inconsistent with our data, the nucleocapsid proteins VP76
and VP51 were thought to be WSSV envelope proteins in
previous reports (11, 12). We therefore prepared nine antibod-
ies against specific structural proteins, including VP150, VP95,
VP76, VP52A, VP52B, VP51, VP41A, VP41B, and VP12. Im-
munoblotting using these antibodies was performed for not
only further confirming the MS data but also making an un-
ambiguous characterization of proteins with controversy. Ex-
cept for VP12, eight other proteins were detected by Western
blotting using specific antibodies as expected (Fig. 3). VP150,
VP52A, VP52B, VP41A, and VP41B were found completely in
the viral envelope fraction, confirming that they are all vial
envelope proteins. In addition, five bands (Fig. 2, bands 2, 7, 8,
9, and 11) in the envelope fraction were detected by Western
blotting with antibody against VP150. We speculate that four
proteins with smaller molecular masses are likely truncated
forms of VP150 (see Discussion). VP76 and VP51 were
present in the nucleocapsid fraction exclusively after normal
detergent extraction. We further attempted to reextract the
pellet with a high-salt (0.8 M NaCl and 0.8 KCl) buffer and a
low pH (0.1 M glycine, pH 2.5). VP76 and VP51 remained in
the pellet fraction after two stringent treatments (data not
shown). Based on these data, we can conclude that VP76 and
VP51 should be components of the nucleocapsid and not the
envelope. VP95 was confirmed to partition consistently in both
the envelope and the nucleocapsid fractions (see Discussion).
The results of Western blotting indicated that our MS data
were credible to some extent.
Characteristics of WSSV structural proteins. Among 30
structural proteins identified, 20 have potential transmem-
brane (TM) domains, 12 have a predicted signal peptide, and
6 have an RGD motif (Table 1). Other than these predicated
structures, there is no obvious sequence homology with any
known proteins (43).
FIG. 2. Coomassie brilliant blue-stained 12% SDS-PAGE gel of WSSV envelope proteins (EP) and nucleocapsid proteins (NP). Numbers
indicate the excised bands. M, protein molecular mass marker (kDa).
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In this study, the glycosylation and phosphorylation statuses
of the WSSV structural proteins were further analyzed. The
structural proteins were separated by SDS-PAGE followed by
glycoprotein detection. The result showed that all of the WSSV
structural proteins were not glycosylated (data not shown),
consistent with a previous report (31). The phosphorylation
experiment depended on the specificity of antibodies for phos-
phothreonine, phosphotyrosine, and phosphoserine. As shown
in Fig. 4, both VP28 and VP19 were phosphorylated on threo-
nine residues, whereas no band was detected using antibody
against phosphotyrosine or phosphoserine. In addition, no pos-
itive signal was detected in the nucleocapsid samples (data not
shown), suggesting that the nucleocapsid proteins are not
phosphorylated.
Interaction of VP28 with VP26 and VP24. Our previous
attempt using native PAGE to separate WSSV envelope pro-
teins indicated that interactions between viral envelope pro-
teins are likely to exist (unpublished data). A recent study
showed that VP24 interacts with the most abundant envelope-
associated protein, VP28 (41). Since VP28 is such an important
protein that it might play a key role in the virus life cycle, we
are interested in determining whether VP28 interacts with
other structural proteins to facilitate functional exploration.
Far-Western experiments using biotinylated rVP28 were per-
formed. The viral structural proteins were separated by SDS-
PAGE, transferred to a membrane, renatured, and subse-
quently incubated with biotinylated rVP28 or biotinylated GST
as a negative control. After detection, we observed two prom-
inent bands corresponding to VP26 and VP24 (Fig. 5A). No
signal was detected in the GST control.
To further confirm the far-Western results, coimmunopre-
cipitation analysis was performed. As shown in Fig. 5B, both
FIG. 3. Western blotting of eight structural proteins of WSSV. The
intact virions (WSSV) were divided into the envelope (EP) and nu-
cleocapsid (NP) fractions after treatment with 1% TX and 0.15 M
NaCl.
TABLE 1. WSSV envelope and nucleocapsid proteins identified in this study
Band no. Proteinnamea
WSSV ORF forb: ORF sizec
Method(s)d Sequencecoverage (%)
Predicted
structureeCN TW TH No. ofamino acids Mass (kDa)
1 VP187 wsv209 WSSV264 ORF108 1,606 174 MS 23 TM
2, 7, 8, 9, 11 VP150 wsv011 WSSV067 ORF036 1,301 144 MS, Ab 40 TM, SP
3 VP124 wsv216 WSSV271 ORF111 1,194 132 MS 23 TM
4 VP110 wsv035 WSSV092 ORF041 972 108 MS 39 TM, SP, RGD
5, 29 VP95 wsv442 WSSV502 ORF006 800 89 MS, Ab 35 TM
6 VP90 wsv327 WSSV383 ORF159 856 96 MS 24 TM, RGD
10 VP56 wsv325 WSSV381 ORF158 465 51 MS 34 TM, SP
12 VP52A wsv238 WSSV294 ORF119 486 51 MS, Ab 52 TM, SP
12 VP52B wsv256 WSSV311 ORF128 384 43 MS, Ab 31 TM, SP
13 VP41A wsv237 WSSV293 ORF118 292 33 MS, Ab 10
13 VP41B wsv242 WSSV298 ORF120 300 34 MS, Ab 34 TM
14 VP39 wsv339 WSSV395 ORF162 283 32 MS 29
15 VP38 wsv259 WSSV314 ORF129 309 35 MS 37
16 VP33 wsv254 WSSV309 ORF127 281 32 MS 31 RGD
17 VP32 wsv198 WSSV253 ORF102 278 31 MS 28
18 VP31 wsv340 WSSV396 ORF163 261 30 MS 12 RGD
19 VP28 wsv421 WSSV480 ORF001 204 22 MS 45 TM, SP
20 VP26 wsv311 WSSV367 ORF153 204 22 MS 56 TM, SP
21 VP24 wsv002 WSSV058 ORF031 208 23 MS 38 TM, SP
22 VP19 wsv414 WSSV473 ORF182 121 13 MS 6 TM, SP
23 VP16 wsv321 WSSV377 ORF155 117 13 MS 12 TM, SP
24 VP14 WSSV349 ORF144 97 11 MS 25 TM, SP
25 VP12 wsv009 WSSV065 ORF034 95 11 MS 9
26 VP664 wsv360 WSSV419 ORF167 6,077 664 MS 64 TM, RGD
27 VP190 wsv289 WSSV344 ORF143 1,565 174 MS 68 TM, SP
28 VP136 wsv271 WSSV326 ORF134 1,218 135 MS 41 TM, RGD
30 VP76 wsv220 WSSV275 ORF112 674 76 MS, Ab 28
31 VP60 wsv415 WSSV474 ORF183 544 62 MS 32 TM
32 VP51 wsv308 WSSV364 ORF151 466 52 MS, Ab 12
33 VP15 wsv214 WSSV269 ORF109 80 9 Ab
a Based on the apparent molecular mass of the protein on 12% SDS-PAGE.
b Based on three WSSV isolates. CN, China; TW, Taiwan; TH, Thailand. The accession numbers are AF332093, AF440570, and AF369029, respectively.
c Size of ORFs in amino acids and predicted molecular mass (kDa).
d Method used for protein identification. MS, MALDI MS; Ab, antibody (Western blotting).
e The presence of putative structures. SP, signal peptides; RGD, cell attachment domain.
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VP26 and VP24 were immunoprecipitated with anti-VP28 an-
tibody but not with anti-GST antibody. Since anti-VP28 anti-
body did not cross-react with VP26 and VP24 (Fig. 4), these
results indicated that VP28 interacted with VP26 and VP24. It
is worth noting that VP28 precipitated with antibody migrated
as three bands with similar molecular masses. This observation
is in agreement with previous studies showing that VP28 has
three forms (11, 29).
DISCUSSION
To date, the entry pathway or assembly process of WSSV has
not yet been defined due to the lack of adequate understanding
of the biological properties of the viral envelope and nucleo-
capsid proteins. In order to obtain information about the full
set of viral proteins that compose the virion, the purity and
quantity of virus preparations are very critical. In previous
reports, WSSV virions were isolated directly from the hemo-
lymph of the infected crayfish by density gradient centrifuga-
tion and the resulting preparations contained generally crayfish
hemocyanin, a major hemolymph protein (
72 kDa) (29, 32).
In addition to hemocyanin, some other cellular proteins, such
as actin and vitellogenin, were also found in the virion protein
profiles (29). We consider that these cellular proteins are not
constituents of WSSV virions, but nonspecifically copurified
with the virions, and that the presence of these contaminants in
virion preparations may interfere with the identification of the
viral structural proteins, especially some quite low-abundant
proteins. On the other hand, we cannot exclude the possibility
that some viral nonstructural proteins adhere to the cellular
proteins, especially hemocyanin, which is considered a multi-
functional molecule possessing osmoregulation, protein stor-
age, or enzymatic activities (38) as well as antiviral or antibac-
terial properties (8, 17). In this study, we purified a large
amount of intact WSSV virions with higher purity by using a
more efficient method and made a more clear protein profile of
WSSV virions, in which those cellular proteins were not ob-
served. In addition, our previous study revealed that the puri-
fied WSSV virions by this approach still keep strong infectivity
(42). Subsequently, a total of 30 structural proteins were iden-
tified from purified WSSV virions. We could be reasonably
sure that this protein profile is more accurate and comprehen-
sive than those that have previously been reported, because
nearly all of the proteins that appear in the SDS-PAGE gel
were identified as WSSV-encoded proteins by MALDI MS
and/or Western blotting.
Detergents are indispensable in the isolation of envelope
proteins from the enveloped virion to study their intrinsic
structural and functional properties. However, not all types of
detergents are suitable for each envelope protein (18). In this
study, the effects of different types of detergents clearly indi-
cated that the envelope of WSSV is most susceptible to the
nonionic detergent TX or NP-40. We also noted that most of
the envelope-associated proteins can be released from WSSV
virions and maintain solubility with TX, with two exceptions.
Both VP26 and VP95 partitioned in both the envelope and
nucleocapsid fractions at zero or very low NaCl concentrations
(Fig. 1C, lanes 5 and 6). In our previous study, we have pro-
vided evidence that VP26 is associated with both the envelope
and the nucleocapsid of WSSV, and we have speculated that it
might function as a matrix-like linker protein between the
envelope and the nucleocapsid (40). In this study, we under-
took a more detailed biochemical characterization of VP26.
The results showed that the extraction of VP26 was variable at
different salt concentrations and that VP26 was present exclu-
sively in the envelope fraction when virions were subjected to
treatment with 1% Triton X-100 and 0.5 M NaCl (data not
shown). On the basis of our present data, we suggest that VP26
is only loosely bound to the nucleocapsid so that it can be
released completely from the nucleocapsid with detergent un-
der high-salt conditions. Similar results regarding dual associ-
ation of VP26 were independently obtained by Tsai et al. (28).
As for VP95, however, we consider this possibility unlikely,
since about 40% of VP95 still remained in the nucleocapsid
fraction even after treatment with 1% Triton X-100 under
high-salt conditions (0.8 M NaCl and 0.8 M KCl) (unpublished
data).
Bands 2, 7, 8, 9, and 11 of the envelope fraction were all
identified by MS as the gene product of ORF wsv011, which
encodes a 144-kDa polypeptide that shows a partial homology
to flagellins of E. coli (43). Except band 2, the apparent mo-
lecular masses of the other four proteins determined from the
1D gel were smaller than expected, and the tryptic mass spec-
tra of four bands obtained from MS were found to map exclu-
sively to the C-terminal domain of the protein, suggesting that
the N-terminal domains of four proteins were all removed. In
a previous study, a protein with an apparent molecular mass of
53 kDa was also identified as the gene product of ORF wsv011
FIG. 4. Phosphorylation analysis of WSSV envelope proteins. The
left panel shows the SDS-PAGE gel of WSSV envelope proteins, the
middle three panels show Western blotting of an equivalent gel probed
with a biotin-conjugated mouse monoclonal antibody directed against
phosphothreonine (P-Thr), phosphotyrosine (P-Tyr), and phospho-
serine (P-Ser), and the right two panels show Western blotting with
anti-VP28 (1:3,000) and anti-VP19 (1:3,000) antibodies.
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(referred to as VP53A) (29), which is in agreement with our
observation (the molecular mass of band 11 is 53 kDa). Here,
we offer two possible explanations for the presence of multiple
forms of VP150. First, they might represent a deliberate pro-
teolytic processing of the protein which appears to be neces-
sary for virus assembly, as is observed with many viruses (1, 25,
36). Another possibility could be that VP150 is highly sensitive
to proteases and easily degraded during the process of purifi-
cation. These truncated forms are derived from the different
degraded products of VP150.
Glycosylated envelope proteins are very common in animal
viruses and often play critical roles in receptor attachment and
membrane fusion (9, 34). For WSSV, however, none of the
structural proteins appear to be glycosylated, which is an un-
usual feature among enveloped animal viruses. Differing from
those of many enveloped viruses, the formation of the WSSV
envelope takes place in the nucleus, which might be responsi-
ble for the lack of glycosylation in WSSV. In addition to gly-
cosylation, protein phosphorylation is a basic mechanism for
the posttranslational modification of protein function in eu-
karyotic cells (14). Our studies revealed that both VP28 and
VP19 are threonine phosphorylated. For WSSV structural pro-
teins, this study represents their first characterization by phos-
phorylation analysis. In vaccinia virus, envelope protein phos-
phorylation is required to form the viral membranes associated
with immature virions (1). Further research will be performed
to test which kinase mediates phosphorylation of VP28 and
VP19 and whether envelope protein phosphorylation plays a
role in WSSV morphogenesis.
As previously described, the most abundant envelope pro-
tein, VP28, encoded by ORF wsv421, has three forms with
similar molecular masses (11, 29). In this study, we also de-
tected three proteins corresponding to VP28, thus confirming
previous data. Moreover, in our initial attempt to separate
envelope proteins by 2D gels, we noted that VP28 migrated as
three spots with similar molecular masses but different pIs
(data not shown). It is not known what might lead to these
different pI forms of the protein. Attempts to show glycosyla-
tion modification added to the protein have been unsuccessful.
Therefore, we speculate that these forms may correspond to
different phosphorylation states (known to make the pIs of
proteins more acidic) of VP28.
Four proteins identified in the nucleocapsid fraction are
predicted to have TM domains (Table 1); however, these are
perhaps just hydrophobic regions that might not function as
TM domains, since the TM signals of these four proteins are
much lower than those of typical envelope proteins, such as
VP28 and VP19. Among 23 proteins in the envelope fraction,
several proteins do not possess potential TM domains and
behave mostly like soluble proteins, indicating that these pro-
teins are not integral envelope proteins. Therefore, we postu-
late that these proteins attain their envelope association
FIG. 5. (A) Far-Western analysis using biotinylated rVP28. The left panel shows the SDS-PAGE gel of WSSV envelope proteins, the middle
two panels show far-Western analysis of an equivalent gel with biotinylated rVP28 (Bio-VP28) and biotinylated GST (Bio-GST), and the right two
panels show Western blotting with anti-VP26 (1:3,000) and anti-VP24 (1:3,000) antibodies. (B) Coimmunoprecipitation of VP26 and VP24 with
anti-VP28 antibody. The FITC-labeled envelope proteins (FITC-EP) were prepared and incubated with antiserum directed to VP28 (Anti-VP28)
or GST (Anti-GST). The immunoprecipitated products were resolved by SDS-PAGE and visualized by fluorescent scanning. The numbers on the
left correspond to the molecular masses of the marker proteins. VP28, VP26, and VP24 are indicated on the right.
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through interaction with other integral envelope proteins. In
many enveloped viruses, such as vaccinia virus and herpesvirus,
a number of interactions have been demonstrated between
structural proteins (5, 7, 13, 35), and protein-protein interac-
tions are suggested to be essential for virion morphogenesis
(27). Further exploration of the biochemical interactions of
WSSV structural proteins might help to elucidate the molec-
ular mechanisms of virion morphogenesis. In this study, addi-
tional in vitro experiments provided evidence for the direct
interaction of VP28 with VP26 and VP24. Since VP26 is be-
lieved to be a key element in the linkage between the viral
nucleocapsid and the envelope, it is possible that the stability
of a ternary complex composed of VP28, VP26, and VP24 is
important for virion morphogenesis, especially when the naked
nucleocapsid is wrapped inside the envelope. This possibility
will be investigated in the future.
In conclusion, this study is the most comprehensive bio-
chemical analysis for the structural proteins of WSSV so far.
Efforts to identify additional associations between structural
proteins are in progress. We anticipate that further exploration
of the function of structural proteins will facilitate a better
understanding of the molecular mechanism underlying WSSV
infection and assembly and may be helpful for the diagnosis
and control of virus infection.
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